Sarcosine (N-methylglycine) trial for individuals at risk for developing schizophrenia and related disorders
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Sarcosine (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- 04 Jun 2014 Biomarkers information updated
- 18 Jun 2012 Actual patient number is 0 as reported by ClincialTrials.gov.
- 18 Jun 2012 Actual end date (1 Jan 2009) added as reported by ClinicalTrials.gov.